Geographic Location Significantly Impacts Prostate Cancer Treatment and Outcomes in U.S. Rural Areas
A Pennsylvania study involving over 51,000 prostate cancer patients revealed that rural men are significantly less likely to receive treatment for prostate cancer compared to their urban counterparts. Specifically, rural men were 23% less likely to be treated for low-risk disease, 29% less for intermediate-risk, and 32% less for high-risk disease, even after accounting for age, overall health, and tumor stage. Furthermore, rural Medicare patients were 18% less likely to receive advanced tissue-based biomarker testing, which is crucial for targeted precision therapies. This disparity highlights that a patient's geographic location, rather than their biology, often dictates their access to critical cancer care. Over 60% of federally designated primary care shortage areas are in rural counties, with more than 7% of U.S. counties lacking a single practicing family doctor. This forces rural patients to travel long distances for basic check-ups and specialized care, exacerbating existing health inequities.